72
Views
6
CrossRef citations to date
0
Altmetric
Original Research

A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior

, , , , , , & show all
Pages 7801-7818 | Published online: 21 Nov 2018

References

  • ParveenSMisraRSahooSKNanoparticles: a boon to drug delivery, therapeutics, diagnostics and imagingNanomedicine20128214716621703993
  • ToyRBauerLHoimesCGhaghadaKBKarathanasisETargeted nanotechnology for cancer imagingAdv Drug Deliv Rev201476799725116445
  • MaXZhaoYLiangXJTheranostic nanoparticles engineered for clinic and pharmaceuticsAcc Chem Res201144101114112221732606
  • DavisMEThe first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinicMol Pharm20096365966819267452
  • SankhalaKMitaAAdininRA phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatinJ Clin Oncol20092715S2535
  • LiJWangYLiangRRecent advances in targeted nanoparticles drug delivery to melanomaNanomedicine201511376979425555352
  • KooHHuhMSSunICIn vivo targeted delivery of nanoparticles for theranosisAcc Chem Res201144101018102821851104
  • ShiJXiaoZKamalyNFarokhzadOCSelf-assembled targeted nanoparticles: evolution of technologies and bench to bedside translationAcc Chem Res201144101123113421692448
  • AllenTMCullisPRLiposomal drug delivery systems: from concept to clinical applicationsAdv Drug Deliv Rev2013651364823036225
  • Al-JamalWTKostarelosKLiposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nano-medicineAcc Chem Res201144101094110421812415
  • Al-AhmadyZKostarelosKChemical components for the design of temperature-responsive vesicles as cancer therapeuticsChem Rev201611663883391826934630
  • RavarFSaadatEGholamiMHyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluationJ Control Release2016229102226968799
  • KunjachanSEhlingJStormGKiesslingFLammersTNoninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospectsChem Rev201511519109071093726166537
  • RyuJHLeeSSonSTheranostic nanoparticles for future personalized medicineJ Control Release201419047748424780269
  • JokerstJVGambhirSSMolecular imaging with theranostic nanoparticlesAcc Chem Res201144101050106021919457
  • ChenFHongHZhangYIn vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticlesACS Nano20137109027903924083623
  • de BarrosABTsourkasASabouryBCardosoVNAlaviAEmerging role of radiolabeled nanoparticles as an effective diagnostic techniqueEJNMMI Res2012213922809406
  • LiuYWelchMJNanoparticles labeled with positron emitting nuclides: advantages, methods, and applicationsBioconjug Chem201223467168222242601
  • HamoudehMKamlehMADiabRFessiHRadionuclides delivery systems for nuclear imaging and radiotherapy of cancerAdv Drug Deliv Rev200860121329134618562040
  • PetersenALHansenAEGabizonAAndresenTLLiposome imaging agents in personalized medicineAdv Drug Deliv Rev201264131417143522982406
  • SeoJWZhangHKukisDLMearesCFFerraraKWA novel method to label preformed liposomes with 64Cu for positron emission tomography (PET) imagingBioconjug Chem200819122577258418991368
  • LiSGoinsBZhangLBaoANovel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imagingBioconjug Chem20122361322133222577859
  • SeoJWMahakianLMTamSThe pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor modelNucl Med Biol201542215516325451215
  • AbouDSThorekDLRamosNN89Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancerPharm Res201330387888823224977
  • NayerossadatNMaedehTAliPAViral and nonviral delivery systems for gene deliveryAdv Biomed Res201212723210086
  • KoideHOkamotoATsuchidaHOne-step encapsulation of siRNA between lipid-layers of multi-layer polycation liposomes by lipoplex freeze-thawingJ Control Release20162281826826309
  • DassCRBiochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapyInt J Pharm2002241112512086717
  • DassCRChoongPFSelective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicabilityJ Control Release2006113215516316764960
  • DuarteSFanecaHLimaMCFolate-associated lipoplexes mediate efficient gene delivery and potent antitumoral activity in vitro and in vivoInt J Pharm2012423236537722209825
  • TagamiTSuzukiTMatsunagaMAnti-angiogenic therapy via cationic liposome-mediated systemic siRNA deliveryInt J Pharm20124221–228028922101286
  • HeZYWeiXWLuoMFolate-linked lipoplexes for short hairpin RNA targeting claudin-3 delivery in ovarian cancer xenograftsJ Control Release2013172367968924144916
  • BadeaIVerrallRBaca-EstradaMIn vivo cutaneous interferon-gamma gene delivery using novel dicationic (gemini) surfactant-plasmid complexesJ Gene Med2005791200121415895387
  • WettigSDWangCVerrallREFoldvariMThermodynamic and aggregation properties of aza- and imino-substituted gemini surfactants designed for gene deliveryPhys Chem Chem Phys20079787187717287881
  • WettigSDBadeaIDonkuruMVerrallREFoldvariMStructural and transfection properties of amine-substituted gemini surfactant-based nanoparticlesJ Gene Med20079864965817654656
  • YangPSinghJWettigSFoldvariMVerrallREBadeaIEnhanced gene expression in epithelial cells transfected with amino acid-substituted gemini nanoparticlesEur J Pharm Biopharm201075331132020417276
  • Mohammed-SaeidWMichelDEl-AneedAVerrallRELowNHBadeaIDevelopment of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexesJ Pharm Pharm Sci201215454856723106958
  • ZhangYHongHCaiWPET tracers based on Zirconium-89Curr Radiopharm20114213113922191652
  • DeriMAZeglisBMFrancesconiLCLewisJSPET imaging with 89Zr: from radiochemistry to the clinicNucl Med Biol201340131422998840
  • VugtsDJvan DongenGA(89)Zr-labeled compounds for PET imaging guided personalized therapyDrug Discov Today Technol201182–4e53e6124990263
  • TurnerDCGrunerSMX-ray diffraction reconstruction of the inverted hexagonal (HII) phase in lipid-water systemsBiochemistry1992315134013551736992
  • VosjanMJPerkLRVisserGWConjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamineNat Protoc20105473974320360768
  • PerkLRVosjanMJVisserGWp-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imagingEur J Nucl Med Mol Imaging201037225025919763566
  • AlmoftiMRHarashimaHShinoharaYAlmoftiABabaYKiwadaHCationic liposome-mediated gene delivery: biophysical study and mechanism of internalizationArch Biochem Biophys2003410224625312573284
  • WasunguLHoekstraDCationic lipids, lipoplexes and intracellular delivery of genesJ Control Release2006116225526416914222
  • MehnertWMäderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev2001472–316519611311991
  • TsengYCXuZGuleyKYuanHHuangLLipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastasesBiomaterials201435164688469824613050
  • Al-DulaymiMAChitandaJMMohammed-SaeidWDi-peptide-modified gemini surfactants as gene delivery vectors: exploring the role of the alkyl tail in their physicochemical behavior and biological activityAAPS J20161851168118127184577
  • ZeglisBMDavisCBAggelerREnzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistryBioconjug Chem20132461057106723688208
  • KeliherEJYooJNahrendorfM89Zr-labeled dextran nano-particles allow in vivo macrophage imagingBioconjug Chem201122122383238922035047
  • WangH-EYuH-MLuY-CInternal radiotherapy and dosimetric study for 111In/177Lu-pegylated liposomes conjugates in tumor-bearing miceNucl Instrum Meth A20065692533537
  • BaeYHParkKTargeted drug delivery to tumors: myths, reality and possibilityJ Control Release2011153319820521663778
  • KangCMKooHJLeeSLeeKCOhYKChoeYS64Cu-Labeled tetraiodothyroacetic acid-conjugated liposomes for PET imaging of tumor angiogenesisNucl Med Biol20134081018102424035550
  • van der GeestTLavermanPGerritsDComparison of three remote radiolabelling methods for long-circulating liposomesJ Control Release2015220Pt A23924426514291
  • SakuraiFTeradaTYasudaKYamashitaFTakakuraYHashidaMThe role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexesGene Ther20029161120112612140741
  • LongmireMChoykePLKobayashiHClearance properties of nano-sized particles and molecules as imaging agents: considerations and caveatsNanomedicine (Lond)20083570371718817471
  • KaganLGershkovichPWasanKMMagerDEDual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B dispositionPharm Res2014311354523793994
  • PolyakAPaladeEABaloghLIn vitro and biodistribution examinations of Tc-99m-labelled doxorubicin-loaded nanoparticlesNucl Med Rev Cent East Eur2011142556222219144
  • Pérez-CampañaCGómez-VallejoVPuigivilaMBiodistribution of different sized nanoparticles assessed by positron emission tomography: a general strategy for direct activation of metal oxide particlesACS Nano2013743498350523473535
  • WilhelmSTavaresAJDaiQAnalysis of nanoparticle delivery to tumoursNat Rev Mater20161516014
  • LeeHHoangBFongeHReillyRMAllenCIn vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levelsPharm Res201027112343235520195708
  • LiuTWMacdonaldTDJinCSInherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastasesACS Nano2013754221423223544841
  • Mohammed-SaeidWChitandaJAl-DulaymiMVerrallRBadeaIDesign and Evaluation of RGD-Modified Gemini Surfactant-Based Lipo-plexes for Targeted Gene Therapy in Melanoma ModelPharm Res20173491886189628643235